MONTREAL, Feb. 7 /CNW Telbec/ - Loubac Top Environmental inc. ("Top")
(NEX: LTE.H) announces that it signed a letter of intent with the Millenia
Hope Pharmaceuticals Inc. ("Millenia") and its shareholder, Millenia Hope Inc.
("MHI") providing for the acquisition by Top of certain assets of MHI, namely
patents and patent applications, as well as forty-two percent (42%) of the
issued and outstanding shares in the capital stock of Millenia (collectively,
the Assets"), in consideration of the issuance by Top to MHI of such number of
common shares in its share capital as would provide MHI a controlling interest
in Top, resulting in a reverse take-over of Top by MHI.
MHI is a publicly traded Biopharma Company (MLHP-OTC:BB) focused on
improving the quality of life around the world through a credo of
comprehensive solutions to the problem of world disease. The company's
objective is to fight disease through a portfolio of health products, both
purchased and developed internally by MHI and its team of clinical associates
based around the world, focusing on parasitic diseases, particularly malaria,
and AIDS and other infectious diseases.
The proposed transaction is subject to the satisfaction of several
conditions, including notably the conclusion of a formal asset purchase
agreement, the completion of a due diligence review by Top, Millenia and MHI,
receipt of the required approvals from the shareholders of Top and receipt of
all required regulatory approvals, including from the TSX Venture Exchange.
As soon as the due diligence process has been commenced by Top and the
negotiations regarding the conclusion of a formal asset purchase agreement
have been finalized, a more detailed press release will be issued describing
the terms of the proposed transaction and its related conditions.
About Loubac Top Environmental
Loubac's shares trade on the NEX market under the symbol LTE.H.
The TSX Venture Exchange accepts no liability with regard to the
relevance or accuracy of this press release.
For further information:
For further information: Mr. Gilles Mousseau, President and Chief
Operating Officer, (450) 674-7737, email@example.com